Safety and Tolerability of hCBE-11 in Subjects With Advanced Solid Tumors
NCT00105170
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
13
Enrollment
INDUSTRY
Sponsor class
Conditions
Tumors
Interventions
DRUG:
hCBE-11
Sponsor
Biogen